TEVA Q1 2017 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena

TEVATeva Pharmaceutical Industries Limited

$36B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$5.6B+17.0% YoY

Gross Profit

$2.8B50.1% margin

Operating Income

$895M15.9% margin

Net Income

$580M10.3% margin

EPS (Diluted)

$0.57

QoQ Revenue Growth

-13.3%

Cash Flow

Operating Cash Flow

$470M

Free Cash Flow

$268M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$91.3B

Total Liabilities

$55.5B

Stockholders' Equity

$34.0B

Cash & Equivalents

$900M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.6B	$4.8B	+17.0%
Gross Profit	$2.8B	$2.8B	+1.0%
Operating Income	$895M	$1.2B	-23.2%
Net Income	$580M	$570M	+1.8%